Condition
Lid Wiper Epitheliopathy
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
5 treatments under study, led by Delefilcon A Contact Lenses
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Phase 4 (1)
Trial Status
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Delefilcon A Contact Lenses1
- Etafilcon A Contact Lenses1
- Spectacles1
- Acuvue Oasys1
- Air Optix Night Day Aqua1
Active Sponsors
- University of Houston1
- Alcon Research1
Top Investigators
University of Houston
Alcon Research
University of Houston